TMC PULSE

t m c » p u l s e | m a r c h 2 0 1 6 39 SHORT TAKES UTHealth Researchers Look at Nanotechnology to Help Prevent Preterm Birth U sing nanoparticles to engi- neer a special drug, a team of researchers from the Texas Medical Center, including McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies. Lead investigators of the research are Jerrie S. Refuerzo, M.D., associate professor in the department of obstet- rics, gynecology and reproductive sciences at McGovern Medical School; Biana Godin, Ph.D., assistant professor in the department of nanomedicine at Houston Methodist Research Institute; and Monica Longo, M.D., Ph.D., associ- ate professor of obstetrics, gynecology and reproductive sciences at McGovern Medical School. The findings were presented by Refuerzo during the Society for Maternal-Fetal Medicine's 36th Annual Meeting—The Pregnancy Meeting in Atlanta. Refuerzo is also chair of Quality for Obstetrics and Gynecology/ Women's Services at Children's Memorial Hermann Hospital. Existing tocolytic (anti-contraction or labor-repressant) medications, such as indomethacin, that are used to treat preterm labor can cross the placental barrier and cause heart defects or other problems in the fetus. The team bioengineered an innovative microscopic nanoparticle of indomethacin aimed at reaching the pregnant uterus but not crossing the placenta to the fetus. This tar- geted liposomal indomethacin, called LIPINDORA, was coated with an oxyto- cin receptor antagonist to make it bind to uterine tissue. Refuerzo and the team, which also includes McGovern Medical School's research assistant Alejandra Elder Ontiveros and laboratory manager Nataliya Buleyeva, as well as Houston Methodist Hospital's Fransisca Leonard, Ph.D., were honored by the March of Dimes during the conference. Joe Leigh Simpson, M.D., senior vice president for research and global pro- grams, presented Refuerzo, Godin and Longo with the March of Dimes award for Best Abstract in Prematurity at the meeting. This marks the 13th year that the March of Dimes award has been presented. LIPINDORA was given to near- term pregnant mice and the research- ers found that the treated mice were significantly less likely than controls to have preterm uterine contractions or to deliver prematurely. Preterm birth (birth before 37 weeks of pregnancy) is the No. 1 killer of babies in the United States. About 380,000 babies are born too soon each year in this country, and those who survive an early birth often face an increased risk of a lifetime of health challenges such as breathing problems, cerebral palsy and intellectual disabili- ties. Even babies born just a few weeks early have higher rates of hospitaliza- tion and illness than full-term infants. Refuerzo said the team currently is conducting tests of LIPINDORA's effectiveness in human uterine tissue donated from C-sections, in particular looking for biomarkers to indicate that the tissue has an anti-contraction response to the drug. If successful, the team hopes to begin a Phase I human clinical trial of the drug within the next few years. Two other McGovern Medical School faculty at the conference pre- sented research findings, including a regenerative patch that can be used for in-utero surgery and rates of patient satisfaction among postpartum women. Saul Snowise, M.D., a UTHealth fetal interventional fellow at The Fetal Center at Children's Memorial Hermann Hospital, compared a patch made from human umbilical cord to one made from biocellulose film in an animal model for in-utero repair of spina bifida. The umbilical cord patch showed promising results in cell devel- opment and decreased inflammation. Robyn P. Roberts, M.D., a mater- nal-fetal medicine fellow instructor at McGovern Medical School, studied patient satisfaction in postpartum women. She found that postpartum women who received delayed physician rounding (after 8 a.m.) were more sat- isfied with physician communication and overall hospital experience without prolonging their hospital stay for time of discharge. — Deborah Mann Lake, UTHealth Join San José Clinic for a gallery-inspired evening of fun and philanthropy! Portrait of Compassion Honoree: United Way of Greater Houston Honorary Event Chair: Bob Harvey sanjoseclinic.org/artwithheart for ticket information, sponsorship opportunities and more San José Clinic's mission is to provide quality healthcare and education to those with limited access to such services in an environment that respects the dignity of each person. We are a 501(c)(3) non-profit organization, a United Way agency and a ministry of the Archdiocese of Galveston-Houston. April 16, 2016 | TMCx 2450 Holcombe Boulevard, Houston, TX 77021 T H E P A R K L A N E 1 7 0 1 H E R M A N N D R . | 7 1 3 . 5 2 6 . V I E W 1 7 0 1 H E R M A N N D R . | 7 1 3 . 5 2 6 . V I E W A S K A B O U T O U R G R E A T M O V E I N S P E C I A L S ! • On-Site Storage Included • Assigned Garage Parking • No Water or Garbage Bills • 24hr. Valet & Concierge Service • Pets Accepted • Minutes from Texas Medical Center • Sophisticated Surveillance System • Discount to Texas Medical Center Employees w w w . t h e p a r k l a n e . c o m L U X U R Y A P A R T M E N T S L U X U R Y A P A R T M E N T S

• Cover